Alon Lang
Tel Aviv, TA 69978, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study.
Journal: Gastroenterology report
Published: September 18, 2025
Glucagon-like peptide-1 receptor agonists and Wernicke encephalopathy: A pharmacovigilance study and literature review.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: July 04, 2025
Evaluation of the cecal withdrawal vocal timer in screening colonoscopies for optimizing withdrawal time and adenoma detection rate.
Journal: Therapeutic advances in gastroenterology
Published: November 22, 2024
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma.
Journal: Cancer medicine
Published: May 17, 2024
Unsedated colonoscopy utilizing virtual reality distraction: a pilot-controlled study.
Journal: Surgical endoscopy
Published: March 12, 2024
Disproportionately Low Albumin and High Neutrophil-to-Lymphocyte Ratio in Small Bowel Adenocarcinoma Patients With Long-Duration Crohn's Disease.
Journal: Clinical and translational gastroenterology
Published: July 13, 2022
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma.
Journal: Clinical and translational gastroenterology
Published: July 30, 2021
Prospective Observational Evaluation of Time-Dependency of Adalimumab Immunogenicity and Drug Concentrations: The POETIC Study.
Journal: The American journal of gastroenterology
Published: November 21, 2017
Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.
Journal: Alimentary pharmacology & therapeutics
Published: August 20, 2016
Last Updated: 09/26/2026